Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-4 of 4
Keywords: 6-Hydroxydopamine
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Sara Batelli, Roberto William Invernizzi, Alessandro Negro, Eleonora Calcagno, Serena Rodilossi, Gianluigi Forloni, Diego Albani
Journal:
Neurodegenerative Diseases
Neurodegener Dis (2015) 15 (1): 13–23.
Published Online: 11 December 2014
... composed of the fibrillogenic protein α-synuclein (α-syn). The familial-PD-related protein DJ-1 was reported to reduce dopaminergic degeneration triggered by α-syn or by the dopaminergic-selective neurotoxin 6-hydroxydopamine (6-OHDA). Objective: The aim was to further investigate the role of DJ-1...
Journal Articles
Journal:
Neurodegenerative Diseases
Neurodegener Dis (2012) 11 (1): 49–58.
Published Online: 24 May 2012
...), kills the striatal neurons susceptible in Huntington’s disease. The complex I inhibitor N-methyl-4-phenylpyridium (MPP + ) and 6-hydroxydopamine (6-OHDA) are used to model Parkinson’s disease. Zinc (Zn 2+) accumulates after 3-NPA, 6-OHDA and MPP + in situ or in vivo. Objective: We will investigate...
Journal Articles
Journal:
Neurodegenerative Diseases
Neurodegener Dis (2011) 8 (5): 364–374.
Published Online: 15 April 2011
... , for alleviating the motor deficits induced by 6-hydroxydopamine (6-OHDA) in a mouse model of PD. Before or after unilateral striatal 6-OHDA lesion induction, mice were administered magnolol subchronically; then the apomorphine-induced rotational behaviors of the hemiparkinsonian mice and tyrosine hydroxylase (TH...
Journal Articles
Yasushi Ishida, Keiichi Kawai, Yasuhiro Magata, Ryuichiro Takeda, Hiroyuki Hashiguchi, Hiroshi Abe, Takahiro Mukai, Hideo Saji
Journal:
Neurodegenerative Diseases
Neurodegener Dis (2004) 1 (2-3): 109–112.
Published Online: 30 September 2004
...) and the dopamine precursor analog 6-[ 18 F]fluoro- L -3,4-dihydroxyphenylalanine ([ 18 F]FDOPA), as a measurement of presynaptic dopaminergic function, in the brain after 6-hydroxydopamine lesioning of the medial forebrain bundle in rats. The unilateral lesions were confirmed behaviorally by methamphetamine...